The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
Georgia
>
Lawrenceville
>
Atlanta Biologicals Inc

Atlanta Biologicals Inc

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $7,406 - Tuesday the 28th of August 2012
    Animal And Plant Health Inspection Service
    ANIMAL & PLANT HLTH INSPECT SVC
    ATTN: RHONDA GRAHAM//IAS-6197--2-467//FADDL68629//LAB SUPPLIES(FETAL BOVINE SERUM)
  • $6,500 - Wednesday the 29th of February 2012
    Veterans Affairs Department
    614-MEMPHIS
    FETAL BOVINE SERUM (100ML,100 EA)
  • $6,000 - Wednesday the 18th of January 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    AMBIS# 1578518FETAL BOVINE SERUM (PREMIUM SELECT), LOT NO: C1011
  • $50 - Tuesday the 10th of April 2012
    Veterans Affairs Department
    614-MEMPHIS
    FETAL BOVINE SERUM (100ML,100 EA)
  • $4,959 - Tuesday the 25th of October 2011
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    ATLANTA BIOLOGICALS, INC. [12-005007]
  • $24,984 - Wednesday the 2nd of November 2011
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    ATLANTA BIOLOGICALS, INC. [12-005213]
  • $247 - Monday the 14th of May 2012
    Veterans Affairs Department
    614-MEMPHIS
    FETAL BOVINE SERUM (100ML,100 EA)
  • $13,304 - Friday the 20th of April 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    STANDING ORDER FOR FETAL BOVINE SERUM-PREMIUM SELECT, HEATED INACTIVATED, LOT# C1041, CATALOG# S11550H, (QTY 96 EACH @ $137.54= $13,303.84), TO ORDER ON AS NEED BASIS.
  • $10,080 - Wednesday the 26th of September 2012
    National Institutes Of Health
    NEI R&D CONTRACTS MANAGEMENT BRANCH, OLAO, NIH
    FETAL BOVINE SERUM - PREMIUM SELECT, RPE CULTURE TESTED LOT: G11012 ITEM # S11550 REF# QUOTE # 9677 POC: ARVYDAS MAMINISHKIS BLDG 10 RM 10B01

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.